{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:57:45Z","timestamp":1788976665927,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The classification of idiopathic inflammatory myopathies is challenging due to the large number of clinical, serological, histopathological and genetic findings, as well as the latest findings and developments in the field of myositis research. The latest official classification criteria are the 2017 European Alliance of Associations for Rheumatology (EULAR)\/American College of Rheumatology (ACR) classification criteria for adult and juvenile idiopathic inflammatory myopathies, which have been extensively reviewed in recent years for their applicability, sensitivity and specificity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The sensitivity and specificity of the 2017\u200aACR\/EULAR criteria are sometimes performing better, but usually at the same level as the previous criteria. A large number of further suggestions for amendments to the criteria have been made. In particular there is a need to revise the criteria with regard to the addition of new myositis-specific autoantibodies, newly defined subgroups (especially antisynthetase syndrome, immune medicated necrotizing myopathy and overlap myositis) and possibly the addition of further diagnostic procedures (for instance, muscle MRI or PET CT) to improve the accuracy and timeliness of the criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Efforts to optimize the myositis classification criteria have been extensive in recent years and a new global interdisciplinary collaboration of clinicians is currently taking place based on the previous results with the aim of revising the 2017\u200aEULAR\/ACR classification criteria.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001042","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T12:03:32Z","timestamp":1723464212000},"page":"473-480","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Current efforts and historical perspectives on classification of idiopathic inflammatory myopathies"],"prefix":"10.1097","volume":"36","author":[{"given":"Stefanie","family":"Glaubitz","sequence":"first","affiliation":[{"name":"Department of Neurology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Saygin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Rush University, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet"},{"name":"Department of Gastroenterology, Dermatology and Rheumatology, Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11926-018-0726-4","article-title":"New myositis classification criteria\u2014what we have learned since Bohan and Peter","volume":"20","author":"Leclair","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R6-20250526","first-page":"668","article-title":"Classification criteria for polymyositis and dermatomyositis","volume":"22","author":"Tanimoto","year":"1995","journal-title":"J Rheumatol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshopneuromuscular disorders","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2024.03.001","article-title":"272nd ENMC international workshop: 10 years of progress \u2013 revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318 June 2023, Hoofddorp, The Netherlands","volume":"37","author":"Lilleker","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"R13-20250526","first-page":"403","article-title":"Performance of the 2017\u200aEULAR\/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review","volume":"42","author":"Saygin","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/annrheumdis-2019-215031","article-title":"Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria","volume":"78","author":"Greco","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/art.42150","article-title":"Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology Classification Criteria in patients with idiopathic inflammatory myopathy and anti\u2013melanoma differentiation\u2013associated protein 5 positivity","volume":"74","author":"So","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.reumae.2023.11.001","article-title":"External validation of the 2017\u200aACR\/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies","volume":"20","author":"S\u00e1nchez-Mendieta","year":"2024","journal-title":"Reumatol Cl\u00edn (Engl Ed)"},{"key":"R17-20250526","first-page":"225","article-title":"Issues in the classification of myositis patients: an ongoing process","volume":"42","author":"Zanframundo","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/acr2.11061","article-title":"External validation and evaluation of adding MRI or extended myositis antibody panel to the 2017\u200aEULAR\/ACR Myositis Classification Criteria","volume":"1","author":"Luu","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"R19-20250526","first-page":"keae125","article-title":"Magnetic resonance imaging patterns revealing muscle pathology and clinical features in idiopathic inflammatory myopathies","author":"Shimoyama","year":"2024","journal-title":"Rheumatology"},{"key":"R20-20250526","first-page":"358","article-title":"Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study","volume":"42","author":"Bekta\u015f","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"152107","DOI":"10.1016\/j.semarthrit.2022.152107","article-title":"Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: a systematic literature review","volume":"57","author":"Bentick","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/diagnostics13142316","article-title":"18F]FDG-PET\/CT in idiopathic inflammatory myopathies: retrospective data from a Belgian cohort","volume":"13","author":"Yildiz","year":"2023","journal-title":"Diagnostics"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"e37105","DOI":"10.1097\/MD.0000000000037105","article-title":"Frequency of EMG abnormalities in idiopathic inflammatory myopathies under the EULAR\/ACR classification criteria","volume":"103","author":"Hokkoku","year":"2024","journal-title":"Medicine"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/1756-185X.13605","article-title":"Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR\/ACR in Chinese patients","volume":"22","author":"Zhang","year":"2019","journal-title":"Int J of Rheum Dis"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1136\/annrheumdis-2020-219426","article-title":"Correspondence on \u2018EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups\u2019","volume":"82","author":"Mohammad","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.2147\/JIR.S433239","article-title":"Sarcoplasmic myxovirus resistance protein a: a study of expression in idiopathic inflammatory myopathy","volume":"16","author":"Waisayarat","year":"2023","journal-title":"J Inflamm Res"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjd.18096","article-title":"Developing classification criteria for skin-predominant dermatomyositis: the Delphi process","volume":"182","author":"Concha","year":"2020","journal-title":"Br J Dermatol"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"309","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining antisynthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/annrheumdis-2019-216599","article-title":"Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis","volume":"79","author":"Pinal-Fernandez","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"104804","DOI":"10.1016\/j.ebiom.2023.104804","article-title":"Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies","volume":"96","author":"Leclair","year":"2023","journal-title":"EBioMedicine"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.chest.2023.01.031","article-title":"Diagnosis and management of myositis-associated lung disease","volume":"163","author":"Hallowell","year":"2023","journal-title":"Chest"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:18:42Z","timestamp":1748294322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001042","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]}}}